Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.

The heterogeneous nature of breast cancer can make decisions on adjuvant chemotherapy following surgical resection challenging. Oncotype DX is a validated gene expression profiling test that predicts the likelihood of adjuvant chemotherapy benefit in early-stage breast cancer. The aim of this study...

Full description

Bibliographic Details
Main Authors: Gregory Katz, Olivier Romano, Cyril Foa, Anne-Lise Vataire, Jean-Victor Chantelard, Robert Hervé, Hugues Barletta, Axel Durieux, Jean-Pierre Martin, Rémy Salmon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4472722?pdf=render

Internet

http://europepmc.org/articles/PMC4472722?pdf=render

Similar Items